Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights

Go back to Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights
(NASDAQ: AKTX) Delayed: 10.15 -0.22 (2.12%)
Previous Close $10.37    52 Week High $19.75 
Open $10.09    52 Week Low $7.63 
Day High $10.40    P/E N/A 
Day Low $9.60    EPS $0.00 
Volume 46,499       

(NASDAQ: AKTX) Delayed: 10.15 -0.22 (2.12%)
Previous Close $10.37    52 Week High $19.75 
Open $10.09    52 Week Low $7.63 
Day High $10.40    P/E N/A 
Day Low $9.60    EPS $0.00 
Volume 46,499